ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/
10-Q, EX-27, 2000-08-21
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, 10-Q, 2000-08-21
Next: CIM HIGH YIELD SECURITIES, DEF 14A, 2000-08-21



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                             261
<SECURITIES>                                         0
<RECEIVABLES>                                    2,623
<ALLOWANCES>                                      (33)
<INVENTORY>                                      1,200
<CURRENT-ASSETS>                                 4,835
<PP&E>                                           7,664
<DEPRECIATION>                                   4,061
<TOTAL-ASSETS>                                  10,332
<CURRENT-LIABILITIES>                              859
<BONDS>                                            412
                                0
                                          0
<COMMON>                                            37
<OTHER-SE>                                       8,994
<TOTAL-LIABILITY-AND-EQUITY>                    10,332
<SALES>                                          4,407
<TOTAL-REVENUES>                                 5,407
<CGS>                                            2,957
<TOTAL-COSTS>                                    1,366
<OTHER-EXPENSES>                                    88
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  14
<INCOME-PRETAX>                                  1,066
<INCOME-TAX>                                       235
<INCOME-CONTINUING>                                746
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       746
<EPS-BASIC>                                        .22
<EPS-DILUTED>                                      .21


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission